Business Development

Emisphere is interested in partnering with biopharmaceutical, consumer health or nutritional companies that have compounds with proven therapeutic activity which need enhanced bioavailability or shortened absorption time.  The “sweet spot” for Eligen®Technology is in delivering injectable compounds in oral form, but Eligen® Technology is often well suited to improve overall absorption and decrease Tmax.  Strategic Partnerships “Best Use” conditions for Eligen® focus on:

We would like to collaborate with companies looking to utilize Eligen® Delivery Technology to enhance their own biopharmaceutical, OTC or nutritional compound(s) or potentially extend the product’s lifecycle.

Partnerships In Place

The following is a list of some of the commercialization and development partnerships Emisphere currently has in place. To learn more about these partnerships, please visit the press release section of this website.

Partnership and Development Opportunities

Emisphere welcomes inquiries from companies interested in working together to develop enhanced pharmaceutical, consumer health, or nutritional products.

If your company has a partnering opportunity, please contact Emisphere’s business development department at bd@Emisphere.com or 973.532.8010.